drugset / Trial / NCT00582582
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
Phase 2
Terminated
70 enrolled
University of Wisconsin, Madison
Genzyme, a Sanofi Company · collabSanofi · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to find out the toxicities of doxercalciferol given in combination with docetaxel (Taxotere®), as well as to see how well this combination works in the treatment of prostate cancer.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxercalciferol | Small molecule | 10 ug | Oral |
| Background | Docetaxel | Small molecule | 35 mg/m2 | Intravenous |